George B. Rathmann

George B. Rathmann

Geen lopende functies

Health Technology
Commercial Services
Consumer Services

Profiel

George B.
Rathmann
was the founder of ICOS Corp.
(founded in 1989) and Amgen, Inc. (founded in 1980) where he held the titles of Chairman, President & Chief Executive Officer and Director respectively.
He also held former positions as Chairman of Biotechnology Innovation Organization and CEPTYR, Inc., Director of Nuvelo, Inc. and ZymoGenetics, Inc., and as a Member of the Board of Directors for Cellerant Therapeutics, Inc. and Warren Pharmaceuticals, Inc. Additionally, he was a Member of the American Chemical Society, National Academy of Engineering, and American Association for the Advancement of Science.
Dr. Rathmann received his undergraduate degree from Northwestern University and his doctorate from Princeton University.

Eerdere bekende functies van George B. Rathmann

BedrijvenFunctieEinde
Directeur/Bestuurslid 22-04-2012
Directeur/Bestuurslid 22-04-2012
Corporate Officer/Principal 22-04-2012
Corporate Officer/Principal 22-04-2012
Nuvelo, Inc. Directeur/Bestuurslid 24-05-2006
Ervaring van George B. Rathmann in detail bekijken

Opleiding van George B. Rathmann

Northwestern University Undergraduate Degree
Princeton University Doctorate Degree

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Ervaring van George B. Rathmann in detail bekijken

Connecties

43

Eerstegraads connecties

13

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Persoonlijk netwerk weergeven

Verwante bedrijven

Beursgenoteerde bedrijven1
AMGEN INC.

Health Technology

Bedrijven in privébezit10

Health Technology

Nuvelo, Inc.

Health Technology

Health Technology

Health Technology

Commercial Services

Commercial Services

Health Technology

Commercial Services

Commercial Services

Health Technology

Zie bedrijfsconnecties
  1. Beurs
  2. Insiders
  3. George B. Rathmann
-40 % Aanbod van beperkte duur: onze abonnementen leiden je naar de beste beleggingen van morgen.
PROFITEER NU